Adjunct assays for improving prostate cancer detection.
作者信息
Bahnson Robert
出版信息
J Urol. 2009 Sep;182(3):825. doi: 10.1016/j.juro.2009.06.030. Epub 2009 Jul 17.
PMID:19616258
Abstract
摘要
相似文献
1
Adjunct assays for improving prostate cancer detection.
J Urol. 2009 Sep;182(3):825. doi: 10.1016/j.juro.2009.06.030. Epub 2009 Jul 17.
2
[Markers of prostatic carcinoma].
Cas Lek Cesk. 1998 Aug 31;137(17):525-7.
3
Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.超越前列腺特异抗原（PSA）：新型肿瘤标志物在PSA升高情况下的应用价值
Urol Oncol. 2009 May-Jun;27(3):315-21. doi: 10.1016/j.urolonc.2009.01.026.
4
Detection of free prostate specific antigen (fPSA) on a nanoporous gold platform.在纳米多孔金平台上检测游离前列腺特异性抗原（fPSA）。
Analyst. 2008 Mar;133(3):319-22. doi: 10.1039/b712760j. Epub 2008 Jan 7.
5
Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development.尿肌氨酸对识别患有严重前列腺癌的患者有用吗？生物标志物开发的试验与磨难。
Eur Urol. 2010 Jul;58(1):19-20. doi: 10.1016/j.eururo.2010.02.025. Epub 2010 Mar 4.
6
Testing for prostate cancer. A consumer view.前列腺癌检测。消费者视角。
Aust Fam Physician. 2003 Jun;32(6):398-9.
7
Many unknowns in low-risk prostate cancer treatment. Ongoing studies and biomarker research may shed light on best approach.
Cancer. 2009 Oct 15;115(20):4645-6. doi: 10.1002/cncr.24672.
8
Trouble in the waterworks: a view from the inside.
J Tenn Med Assoc. 1993 Mar;86(3):125-6.
9
Legal implications of prostate cancer: what you should know.
Va Med Q. 1993 Spring;120(2):77-9.
10
[Should I check the PSA?].
Tidsskr Nor Laegeforen. 1998 Sep 20;118(22):3400.
Zotero 插件